Pancreatic cancer is notoriously lethal. But new treatments mean that may be changing, and people with the disease now have ...

Less than 1 percent of cancers start in the heart, and disease that begins elsewhere seldom spreads to the blood-pumping ...

Since its emergence in 2020, Covid has jumbled the list of the 10 leading causes of deaths in the United States. It roared into third place in 2020 but has now fallen to 10th place, the National ...

New drugs have made America’s deadliest cancer more treatable than ever. So why aren’t they reaching patients?

Moderated discussion with Chief Scientific Officer Dr. Robert Pierce on ovarian cancer and evolving treatment landscape Segment highlights ...

Schlesinger is a physician-scientist and professor, president, and CEO of Texas Biomedical Research Institute, a nonprofit research organization in San Antonio, Texas. The connection between infection ...

Researchers are looking into whether a breakthrough cancer therapy is the missing piece that could treat autoimmune diseases.

Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold under ...

An experimental pancreatic cancer drug that’s been shown to double survival in patients with advanced stages of the disease ...

People with autoimmune skin diseases had significantly better cancer survival outcomes than others. Survival benefits were most notable in people with alopecia areata and Sjögren syndrome. Findings ...

"It feels irresponsible," an oncologist told Newsweek.

Mounting evidence has linked alcohol to higher risks of cancer but many people aren't aware. New findings suggest labels that ...